Ordering From Brill. LibLynx for Selected Online Resources. Discovery Services. Online User and Order Help. MARC Records. Titles No Longer Published by Brill. Latest Key Figures. Latest Financial Press Releases and Reports. Annual General Meeting of Shareholders. Share Information. Specialty Products. Catalogs, Flyers and Price Lists. Open Access.
Open Access for Authors. Open Access and Research Funding. Open Access for Librarians. Open Access for Academic Societies. About us. Stay updated. Corporate Social Responsiblity. Investor Relations. Review a Brill Book. Reference Works. Primary source collections. Open Access Content. Contact us. Sales contacts. Publishing contacts. Social Media Overview. Terms and Conditions. Privacy Statement. Login to my Brill account Create Brill Account. Author: Barry Hawk. Chromosome aberrations and cancer.
Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Sato Y, Rowley JD.
Chromosome abnormalities in hematologic malignant diseases. Hemotology of infancy and childhood. Philadelphia: WB Saunders ; 2: - Antibody recognition of the tumor-specific bcr-abl joining region in chronic myeloid leukemia. J Exp Med ; 87 - Blood ; - Immunogenetics of human cell surface differentiation. Annu Rev Immunol ; 7: - Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. The history of cancer immunotherapy.
Biologic therapy of cancer. Philadelphia: Lippincott-Raven ; 87 - The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen. Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy. J Clin Oncol ; - Lancet ; - Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Rituximab: the first monoclonal antibody approved for the treatment of lymphoma.
Curr Pharm Biotechnol ; 1: 1 - 9. Immunol Today ; - Tla-region genes and their products. Immunol Res ; 6: 30 - Old LJ. Cancer immunology: the search for specificity d G. Clowes Memorial lecture. Highly restricted expression of the thymus leukemia antigens on intestinal epithelial cells. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.
A member of the melanoma antigen-encoding gene MAGE family is expressed in human skin during wound healing. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. The SMAGE gene family is expressed in post-meiotic spermatids during mouse germ cell differentiation. Immunogenetics ; 97 - Identification and characterization of the tumor-specific P1A gene product. Biol Cell ; - The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.
Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics ; - Baskar S. Gene-modified tumor cells as cellular vaccine. Barratt-Boyes SM. Making the most of mucin: a novel target for tumor immunotherapy. Isoantigenic expression of Forssman glycolipid in human gastric and colonic mucosa: its possible identity with "A-like antigen" in human cancer.
Lloyd KO. Philip Levine award lecture. Blood group antigens as markers for normal differentiation and malignant change in human tissues. Am J Clin Pathol ; - The epithelial cell surface antigen A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies.
Int J Cancer ; 47 - Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein. Livingston PO. Approaches to augmenting the immunogenicity of melanoma gangliosides: from whole melanoma cells to ganglioside-KLH conjugate vaccines.
Immunol Rev ; - The role of immunohistochemistry in the diagnosis of poorly differentiated malignant neoplasms.
Cell surface markers in hematologic malignancies. Prostate cancer: emerging concepts. Ann Intern Med ; - Clinical use of posttherapy prostate-specific antigen changes in advanced prostate cancer. Semin Oncol ; 8 - Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of T cell-mediated vitiligo.
Cell surface molecules of human melanoma. Am J Pathol ; - Melanoma antigens and antibodies. In: Dulbecco R, eds. Encyclopedia of human biology. San Diego: Academic Press ; - MUC-1 epithelial tumor mucin-based immunity and cancer vaccines. Immunol Rev ; 61 - N Engl J Med ; - Menschenembryo und Menschenkrebs. Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system.
Thompson JA. Molecular cloning and expression of carcinoembryonic antigen gene family members. Tumour Biol ; 10 - Northover J. The use of prognostic markers in surgery for colorectal cancer. Eur J Cancer ; 31A: - Hodge JW. Carcinoembryonic antigen as a target for cancer vaccines. Production of embryonal a -globulin by transplantable mouse hepatomas.
Transplantation ; 1: - Screening for hepatocellular carcinoma. Eur J Gastroenterol Hepatol ; 8: - Medawar PB, Hunt R. Can fetal antigens be used for prophylactic immunization?.
Ciba Found Symp ; - Myeloma proteins as tumor-specific transplantation antigens. DNA immunization induces protective immunity against B-cell lymphoma.
Nat Med ; 2: - Krensky AM. Immunol Res ; 91 - Antibody against the antigen receptor of a plasmacytoma prolongs survival of mice bearing the tumor.
Schreiber H, Leibson P. Suppression of myeloma growth in vitro by anti-idiotypic antibodies: inhibition of DNA synthesis and colony formation. Some effects on leukaemic B lymphocytes of antibodies to defined regions of their surface immunoglobulin.
Immunology ; - Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med ; 2: 52 - Habel K.
Resistance of polyoma virus immune animals to transplanted polyoma tumors. Proc Soc Exp Biol Med ; - Resistance of polyoma virus-immunized mice to transplantation of established mice to transplantation of established polyoma tumors. Exp Cell Res ; - Defendi V. Effects of SV40 virus immunization on growth of transplantable SV40 and polyoma virus tumors in hamsters.
Proc Soc Exp Biol Med ; 12 - Biology of simian virus 40 SV40 transplantation antigen TrAg. SV40 transplantation antigen: relationship to SVspecific proteins. Cloned cytotoxic T lymphocytes recognize cells expressing discrete fragments of the SV40 tumor antigen. SV40 T antigen and the exocytotic pathway. EMBO J ; 4: - Simian virus large-T antigen binds p53 in human mesotheliomas.
Nat Med ; 3: - T cell recognition of Epstein-Barr virus associated lymphomas. Cancer Surv ; 53 - Adoptive immunotherapy for Epstein-Barr virus-related lymphoma.
Leuk Lymphoma ; - Tindle RW. Human papillomavirus vaccines for cervical cancer. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity.
Nat Med ; 1: - Coffin JM. Endogenous retrovirus. RNA tumor viruses. Polymorphism of murine endogenous proviruses revealed by using virus class-specific oligonucleotide probes. J Virol ; - Mapping of viral proteins with monoclonal antibodies. Monoclonal antibodies. Hybridomas: a new dimension in biological analyses. New York: Plenum Publishing ; - The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences.
Differential expression of cellular oncogenes during pre- and postnatal development of the mouse. Identification of a unique erythroleukemia-associated retroviral gp70 expressed during early stages of normal erythroid differentiation. Induction and regression of primary Moloney sarcoma virus-induced tumors in mice. Plata F, Lilly F. Viral specificity of Hrestricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus.
Retrovirus antigens recognized by cytolytic T lymphocytes activate tumor rejection in vivo. The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product.
Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Thomas L. Discussion of cellular and humoral aspects of the hypersensitive states. In: Lawrence HS, eds. Cellular and humoral aspects of hypersensitivity states. New York: Hoeber-Harper ; - The concept of immunological surveillance.
Prog Exp Tumor Res ; 1 - Stutman O. Cell-mediated immunity and aging. Fed Proc ; - Tumor development after 3-methylcholanthrene in immunologically deficient athymic nude mice. Methylcholanthrene-induced sarcomas in nude mice have short induction times and relatively low levels of surface MHC class I expression.
APMIS ; - MCA sarcomas induced in scid mice are more immunogenic than MCA sarcomas induced in congenic, immunocompetent mice. Scand J Immunol ; - Spontaneous and induced tumor incidence in germfree "nude" mice.
Reticuloendothel Soc ; 1 - 9. Regulation of cutaneous malignancy by gamma delta T cells. IFN gamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Spontaneous and induced primary oncogenesis in natural killer NK -cell-deficient beige mutant mice. Good R. Relations between immunity and malignancy. Kinlein LJ. Immunologic factors including AIDS.
Klein G. Immunological surveillance against neoplasia. Harvey Lect ; 71 - Tooze J. Origins of contemporary tumor virus research. The molecular biology of tumor viruses.
A phase I trial of a human papillomavirus HPV peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive. Clin Cancer Res ; 6: - Genetic predisposition and parameters of malignant progression in KHPV16 transgenic mice. Simian herpesviruses and neoplasia. Adv Cancer Res ; - Systemic deficits in transporter for antigen presentation TAP -1 or proteasome subunit LMP2 have little or no effect on tumor incidence.
Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p Genes Dev ; - Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Decreased tumor surveillance in perforin-deficient mice.
Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation ; - Effects of immunosuppressive therapy on the induction of skin tumors by ultraviolet irradiation in hairless mice. Ability of cyclosporine to promote the growth of transplanted ultraviolet radiation-induced tumors in mice.
Immune suppression and skin cancer development: regulation by NKT cells. Nat Immunol ; 1: - Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells. Greenberg AH, Greene M. Non-adaptive rejection of small tumour inocula as a model of immune surveillance.
In vivo surveillance of tumorigenic cells transformed in vitro. Antigenic cancer cells that escape immune destruction are stimulated by host cells.
Inhibition of tumor growth by elimination of granulocytes. Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice.
Virchow R. Berlin: Verlag von August Hirschwald ; 57 - Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer ; - Histopathology of malignant melanoma and its precursor lesions.
Philadelphia: Lippincott-Raven ; - Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J Clin Invest ; - Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. Schreiber H, Rowley DA. Inflammation and cancer. Inflammation: basic principles and clinical correlates. Cordon-Cardo C, Prives C.
At the crossroads of inflammation and tumorigenesis. A proinflammatory cytokine inhibits p53 tumor suppressor activity. Carcinogen ; - Intimate connections between APC and prostaglandin H synthase Suppression of intestinal polyposis in Apc delta knockout mice by inhibition of cyclooxygenase 2 COX Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis.
Nat Med ; 5: - Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins MCP-2 and MCP-3 belonging to the chemokine family. J Exp Med ; 59 - The role of platelet-derived growth factor production by tumor-associated macrophages in tumor stroma formation in lung cancer.
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol ; - Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells. Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy.
Coussens LM, Werb Z. Inflammatory cells and cancer: think different!. J Exp Med ; F23 - F Science ; Oncogene ; 9: - Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro.
Lu C, Kerbel RS. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.
J Cell Biol ; - Mintz B, Silvers WK. Accelerated growth of melanomas after specific immune destruction of tumor stroma in a mouse model. Strieter RM. Chemokines: not just leukocyte chemoattractants in the promotion of cancer.
Nat Immunol ; 2: - Prehn RT. The immune reaction as a stimulator of tumor growth. Stimulatory effects of immune reactions upon the growths of untransplanted tumors. Bittner JJ. Some possible effects of nursing on the mammary gland tumor incidence in mice. Am J Cancer ; Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. A maternally inherited superantigen encoded by a mammary tumour virus.
Clonal deletion of V beta bearing T cells in mice transgenic for mammary tumour virus. Inhibition of viral DNA synthesis in stationary chicken embryo fibroblasts infected with avian retroviruses. Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA. Intervention of T-cells in transportation of mouse mammary tumor virus milk factor to mammary gland cells in vivo.
Mouse strain and breeding stimulation as factors influencing the effect of thymectomy on mammary tumorigenesis. Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation. DNA vaccination against v-src oncogene-induced tumours in congenic chickens.
Vaccine ; - Rapp HJ. Appropriateness of animal models for the immunology of human cancer. Tumour-specific immunity against spontaneous rat tumours. Int J Cancer ; 1: - Klein G, Klein E. Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution. A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.
Hewitt HB. The choice of animal tumors for experimental studies of cancer therapy. Latency, histology, and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains. Reduced antibody titers in mice treated with carcinogenic and cancer chemotherapeutic agents. Immunologic parameters of ultraviolet carcinogenesis. Ultraviolet light, tumors, and suppressor T cells. Hum Pathol ; - Immunological unresponsiveness induced by ultraviolet radiation.
Immunol Rev ; 87 - Modification of the immunogenic properties of chemically induced tumors arising in hosts treated concomitantly with ultraviolet light.
Bartlett GL. Effect of host immunity on the antigenic strength of primary tumors. Makinodan T, Kay MM. Age influence on the immune system. Adv Immunol ; - Immunoregulation by ultraviolet light d III. Enhancement of suppressor cell activity in older animals. Exp Gerontol ; - Loss of tumor-specific and idiotype-specific immunity with age.
Urban JL, Schreiber H. Rescue of the tumor-specific immune response of aged mice in vitro. Winn HJ. Immune mechanisms in homotransplantation. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts. Analysis of the role of endogenous TNF in endotoxin-induced hemorrhagic necrosis and regression of an established sarcoma.
Selection of macrophage-resistant progressor tumor variants by the normal host. Requirement for concomitant T cell-mediated immunity. The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia.
CD4-positive and B lymphocytes in transplantation immunity. Promotion of tumor allograft rejection through elimination of CD4-positive lymphocytes. Augmented rejection of tumor allografts by mice lacking B cells.
B cells inhibit induction of T cell-dependent tumor immunity. Nat Med ; 4: - Class 1 unique tumor antigens of human melanoma. Identification of a 90, dalton cell surface glycoprotein by autologous antibody. Antibody response of mice to chemically induced tumors. Antigenic properties of experimental leukemias. Serological studies in vitro with spontaneous and radiation-induced leukemias.
Cell-mediated reaction against tumors induced by oncornaviruses. Kinetics and specificity of the immune response in murine sarcoma virus MSV -induced tumors and transplanted lymphomas. Requirement of thymus-derived theta-positive lymphocytes for rejection of DNA virus SV 40 tumors in mice. Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells.
Growth of cells in vivo in diffusion chambers. Survival of homografts in immunized mice. Immunologic mechanisms in UV radiation carcinogenesis. Adv Cancer Res ; 69 - Robins RA. T-cell responses at the host: tumour interface. Biochim Biophys Acta ; - Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.
Awwad M, North RJ. Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. Clonal analysis of cytotoxic T cell response against human melanoma.
T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures. Separation and characteristics of tumor-infiltrating lymphocytes in man. Contemp Top Immunobiol ; 79 - Clonal analysis of the cytolytic T-cell response to human tumors. Immunol Today ; 8: - Reactivity of lymphocytes from normal persons on cultured tumor cells. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype.
Eur J Immunol ; 5: - Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. Distribution of reactivity and specificity.
Joihdal M, Press H. Surface markers on human B and T lymphocytes VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int J Cancer ; Trinchieri G. Biology of natural killer cells. Snell GD. Histocompatibility genes of the mouse. Production and analysis of isogenic resistant lines.
Cudkowicz G, Cosgrove GE. Immunologically competent cells in adult mouse liver: studies with parent-to-hybrid radiation chimeras Selective rejection of Hdeficient lymphoma variants suggests alternative immune defence strategy.
Hanna N, Fidler IJ. Role of natural killer cells in the destruction of circulating tumor emboli. Hanna N, Burton RC. Definitive evidence that natural killer NK cells inhibit experimental tumor metastases in vivo. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
The human lymphokine-activated killer cell phenomenon. Lymphokines ; 9: - Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2.
Mazumder A, Rosenberg SA. Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.
A progress report on the treatment of patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.
Lymphokine-activated killer cells. Analysis of progenitors and effectors. Murine lymphokine-activated killer LAK cells: phenotypic characterization of the precursor and effector cells. Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance. Nat New Biol ; 48 - Control of carcinogenesis: a possible role for the activated macrophage. Evans R, Alexander P. Mechanism of immunologically specific killing of tumour cells by macrophages.
Alterations of macrophage functions by mediators from lymphocytes. Activation of mouse macrophages for tumor cell killing. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.
Meltzer MS. Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation. Lichtenstein A. Granulocytes as possible effectors of tumor immunity.
Immunol Allergy Clin North Am ; - Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol ; - The instructive role of innate immunity in the acquired immune response. Science ; 50 -
0コメント